The short version of REV-ERB agonist fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-10-02. Anything still debated is marked as such rather than presented as settled.
SR9009 is not approved as a medicine by major regulatory agencies. It is commonly sold as a research chemical, a category that may fall outside customary drug approval and quality rules. In sports, the World Anti-Doping Agency lists SR9009 as a prohibited substance. Athletes who use it can face sanctions if it is detected in a sample. Legal status varies by country, and importation may be restricted. Enforcement practices differ across borders.
Detection of SR9009 in biological samples usually employs liquid chromatography coupled with tandem mass spectrometry. This method can identify the parent compound and sometimes metabolites in urine or blood. Because exposure can be low and clearance may be rapid, sample timing and limits of detection matter. Laboratories validate assays for sensitivity and specificity. Results are interpreted alongside chain-of-custody and quality-control records. Urine is the common matrix for anti-doping analysis, while blood may be used in research settings.
Handling recommendations for SR9009 in a laboratory setting include storing the solid at low temperature, protected from light and moisture. The compound is often dissolved in dimethyl sulfoxide or ethanol for experiments. Solutions should be prepared with appropriate personal protective equipment and disposed of according to local rules. Stability data for long-term storage are limited, so stock solutions are typically kept cold and used within defined periods. Records of preparation date and concentration support reproducibility.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms and metabolic gene expression. In laboratory experiments, SR9009 binds these receptors and alters transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. It is not a naturally occurring compound and has no approved therapeutic use. Research interest stems from its ability to modify energy metabolism in cells and animal models.
In rodent studies, SR9009 has been reported to increase mitochondrial content in skeletal muscle and improve exercise endurance under some conditions. These findings led to popular descriptions such as an exercise mimetic, although that term oversimplifies the biology. Effects vary by dose, timing, tissue, and model. The compound's influence on circadian pathways means that time of administration can matter in experiments. Whether similar metabolic changes occur in humans remains largely unexplored in controlled published trials.
Pharmacokinetic data for SR9009 are limited in published literature. Some reports indicate low oral bioavailability and rapid clearance in animals, which complicates interpretation of exposure and effect. Researchers often use injected routes in preclinical work to achieve measurable systemic levels. Analytical studies rely on mass spectrometry to detect the parent compound and its metabolites. Questions about tissue distribution, active metabolites, and long-term consequences remain open. Species differences in metabolism can affect observed half-life and target engagement.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved as a medicine in major jurisdictions | Sold as a research chemical; legal status varies |
| Anti-doping status | Prohibited by the World Anti-Doping Agency | Listed under non-approved substances or related category |
| Typical analytical method | LC-MS/MS | Used for detection and confirmation in biological samples |
| Storage temperature | −20 °C or lower for solid | Desiccated and protected from light |
| Common solution solvents | DMSO; ethanol | Aqueous solubility is limited |
Analytical chemists detect SR9009 with liquid chromatography-tandem mass spectrometry, commonly abbreviated LC-MS/MS. Sample preparation may involve protein precipitation, liquid-liquid extraction, or solid-phase extraction before analysis. Laboratories can target the parent compound or its metabolites, depending on the matrix and the purpose of testing. Anti-doping methods require sensitive and specific assays because concentrations in biological samples can be low. Reference standards and validated methods are essential for reliable identification and quantification.
Regulatory agencies have not approved SR9009 for human therapeutic use. It is typically sold as a research chemical with labels stating that it is not for human consumption. The World Anti-Doping Agency prohibits the substance in sport, generally under the category of non-approved substances. Customs and national laws may restrict importation, sale, or possession. Product quality and legal status can vary by country and vendor, and therapeutic claims are not permitted in regulated advertising because the compound lacks approval.
At the molecular level, SR9009 binds the ligand-binding domain of REV-ERB and strengthens recruitment of corepressor proteins such as NCoR and HDAC3. This increases repression of target genes, including Bmal1 and other clock-controlled and metabolic genes. In rodent studies, such changes have been linked to altered lipid handling, glucose metabolism, and energy expenditure. The precise chain of events between receptor binding and whole-body effects remains an active area of research. Findings in animals do not automatically translate to humans.
Laboratory studies often administer SR9009 by injection because oral absorption appears poor in rodents. Reported pharmacokinetic properties include rapid metabolism and low systemic exposure after oral dosing. Human pharmacokinetic data are sparse, so absorption, distribution, metabolism, and excretion in people are not well defined. Some research explores related REV-ERB compounds with improved drug-like properties. Regulatory approval for any REV-ERB agonist as a human medicine has not been granted to date.
Significant increases in central MP levels were also observed after just two weeks of supplementation. Furthermore, in patients who had an atypical MP distribution in the eye (i.e., they did not have a high concentration of pigment in the centre of the macula), when supplemented with a meso-zeaxanthin-dominant supplement for 8 weeks, the normal pigment profile was reinstated, whereas this was not the case when patients were supplemented with a formulation lacking meso-zeaxanthin. The main findings from the MOST trials in patients with AMD were published in 2013 and 2015. The series of publications from these trials concluded, "Augmentation of the MP optical density across its spatial profile and enhancements in contrast sensitivity were best achieved after supplementation with a formulation containing high doses of meso-zeaxanthin in combination with lutein and zeaxanthin". Also, the final publication from this work, published in 2015, concluded that, "The inclusion of meso-zeaxanthin in a supplement formulation seems to confer benefits in terms of MP augmentation and in terms of enhanced contrast sensitivity in subjects with early AMD.". In 2016 and 2017, the results of two small clinical trials were published. The first trial, the CREST (Central Retinal Enrichment Supplementation Trials) study involved 105 normal healthy volunteers who underwent a series of complex tests of vision and were supplemented over 12 months.
== Rationale == There are several motivating factors behind in-space manufacturing. The space environment, in particular the effects of microgravity and vacuum, enable the research of and production of goods that could otherwise not be manufactured on Earth. Secondly, the extraction and processing of raw materials from other astronomical bodies, also called In-Situ Resource Utilisation (ISRU), could enable more sustainable space exploration missions at reduced cost compared to launching all required resources from Earth. Furthermore, raw materials could be transported to low Earth orbit where they could be processed into goods that are shipped to Earth. By replacing terrestrial production on Earth, this seeks to preserve the Earth. Moreover, raw materials of very high value, for example gold, silver, or platinum, could be transported to low Earth orbit for processing or transfer to Earth which is thought to have the potential to become economically viable. In-space manufacturing supports long-duration space missions and colonization by enabling on-site repair and infrastructure development beyond Earth.
On 8 July, an ambush targeting a military convoy in Lasbela killed 11 Pakistani soldiers, with ISPR stating that 38 security personnel and four civilians had been killed in three major attacks by TTP in Balochistan over the last three days, while also claiming to have killed 54 insurgents in retaliatory operations. A mortar strike in Orakzai District killed a civilian. A military attack on an insurgent roadblock in Nushki District resulted in six insurgents being killed. An attack on a police post in Bannu District was repelled resulting in two insurgents being injured. On 9 July, an Elite Force officer was assassinated by insurgents in Tank District. On 10 July, insurgents destroyed a bridge on the Quetta-Taftan highway in the Batto area of Nushki District. CM Balochistan claimed that 75 terrorists had been killed in various operations since July 5 in Balochistan, with 17 more being killed in Ziarat District, that day bringing the toll of those killed under Operation Shaban to 43. Pakistani forces killed four TTP insurgents under Commander Zahid in Karak District and one more TTP militant in Peshawar as well as launching helicopter strikes against TTP infrastructure in Tank District. Two Policemen were ambushed and killed in Spinwam by insurgents. Two Lashkar-e-Jhangvi militants were also captured from Karachi. On 11 July, suspected TTP drone strike in Tank District killed a school teacher and wounded two civilians. On 12 July, TTP insurgents killed a CTD officer in Totalai. A mortar strike damaged a house in North Waziristan.
Sources: en.wikipedia.org
==== By ions ==== Upon illumination of the chloroplasts, the pH of the stroma rises from 7.0 to 8.0 because of the proton (hydrogen ion, H+) gradient created across the thylakoid membrane. The movement of protons into thylakoids is driven by light and is fundamental to ATP synthesis in chloroplasts (Further reading: Photosynthetic reaction centre; Light-dependent reactions). To balance ion potential across the membrane, magnesium ions (Mg2+) move out of the thylakoids in response, increasing the concentration of magnesium in the stroma of the chloroplasts. RuBisCO has a high optimal pH (can be >9.0, depending on the magnesium ion concentration) and, thus, becomes "activated" by the introduction of carbon dioxide and magnesium to the active sites as described above.
== Non-enzymatic transamination == A second type of transamination reaction can be described as a nucleophilic substitution of one amine or amide anion on an amine or ammonium salt. For example, the attack of a primary amine by a primary amide anion can be used to prepare secondary amines:
Muammar Gaddafi was born near Qasr Abu Hadi, a rural area outside the town of Sirte in the deserts of Tripolitania, Italian western Libya. His family came from a small, relatively uninfluential tribe called the Qadhadhfa, who were of Arab Ashraf heritage, from the lineage of Musa al-Kazim. According to later claims, Gaddafi's paternal grandfather, Abdessalam Bouminyar, was killed by the Italian Army during the Italian invasion of 1911. Subsequently, moving to nearby Sirte to attend elementary school, he progressed through six grades in four years. Growing up, Gaddafi witnessed significant events severely disturb the Arab world, including the 1948 Arab–Israeli War, the Egyptian Revolution of 1952, the Suez Crisis of 1956, and the short-lived existence of the United Arab Republic (UAR) between 1958 and 1961. In October 1961, he led a demonstration protesting against Syria's secession from the UAR and raised funds to send cables of support to Nasser. Twenty students were arrested as a result of the disorder. Gaddafi and his companions also broke windows in a local hotel that was accused of serving alcohol. To punish Gaddafi, the authorities expelled him and his family from Sabha. Gaddafi moved to Misrata, there attending Misrata Secondary School. He graduated from the Benghazi Military College in 1965. In 1966, he went to the United Kingdom for further military training.
Sources: en.wikipedia.org
Its legal status depends on the country and intended use. It is not an approved medicine in major jurisdictions. In sport, it is prohibited by anti-doping rules.
Laboratories typically use LC-MS/MS to detect SR9009 and related compounds in urine or blood. The method is sensitive but depends on sample collection timing. Confirmatory analysis follows quality-control procedures.
Solid material is generally kept cold, dry, and protected from light. Solutions are often stored in sealed containers at low temperature. Stability beyond recommended periods is not well documented.
It is a synthetic research compound that activates REV-ERB nuclear receptors. It is not an approved drug or dietary supplement. Most information comes from cell and animal studies.